BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 9, 2002
View Archived Issues
Life Medical Sciences given green light for trial of Repel-CV in neonatal patients
Read More
Patients enrolling in pivotal PRIMO-CABG trial
Read More
ICN files IND for viramidine
Read More
Telik updates progress of TLK-286
Read More
Abgenix submits IND for ABX-MA1 in metastatic melanoma
Read More
Marketing approval obtained for Replagal in Israel, Switzerland and Czech Republic
Read More
Geron and Genetic Therapy enter licensing agreement to develop cancer therapy
Read More
Fungicidal peptides derived from an active BPI fragment at Xoma
Read More
Noncytotoxic, semisynthetic milbemycin inhibits fungal efflux pump in Candida
Read More
Pharmacokinetics/metabolism of new oxazolidinone PNU-173995 reported at ICAAC
Read More
Naphthyridinone-based FabI/FabK inhibitor with good oral activity in animal infection model
Read More
ICAAC presentations cover development of BB-83698, a new peptide deformylase inhibitor
Read More
Genencor and Johns Hopkins form strategic research collaboration
Read More
Study demonstrates safety, preliminary efficacy of squalamine as 120-hour infusion
Read More
SkyePharma signs agreement to develop HFA-based Pulmicort systems
Read More
Metalloelastase inhibitors reported by Shionogi to have potential in COPD, etc.
Read More
Anti-HIV agents designed by Janssen and reported in patent literature
Read More
Agonists at the alpha7 nicotinic acetylcholine receptor claimed by Novartis
Read More
Antitumor activity demonstrated for new series of caprolactam carbonates
Read More
New growth hormone secretagogues and their use described by BMS
Read More
AstraZeneca patents novel neuropeptide Y5 receptor antagonists
Read More
Millennium initiates phase I clinical program of MLN-341 in combination with Taxotere
Read More
InterMune's Actimmune receives fast track designation for idiopathic pulmonary fibrosis
Read More
Idec's BLA for Zevalin radioimmunotherapy approvable according to FDA
Read More
Emisphere completes enrollment in PROTECT trial of oral heparin
Read More
Study protocol changes following early positive results for Gleevec in CML
Read More
Successful results from Cubist's proof-of-principle study with oral ceftriaxone
Read More